PubMed

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Lund SS, Tarnow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O, Parving HH, Vaag AA.

BMJ. 2009 Nov 9;339:b4324. doi: 10.1136/bmj.b4324.PMID: 19900993 [PubMed - in process]Related articlesFree article

Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.

Tarnow I, Michelson AD, Barnard MR, Frelinger AL 3rd, Aasted B, Jensen BR, Parving HH, Rossing P, Tarnow L.

Platelets. 2009 Nov;20(7):513-9.PMID: 19852691 [PubMed - in process]Related articles

The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.

Möllsten A, Jorsal A, Lajer M, Vionnet N, Tarnow L.

Diabetologia. 2009 Oct 16. [Epub ahead of print]PMID: 19834686 [PubMed - as supplied by publisher]Related articles

Telomere length predicts all-cause mortality in patients with type 1 diabetes.

Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH.

Diabetologia. 2009 Oct 4. [Epub ahead of print]PMID: 19802713 [PubMed - as supplied by publisher]Related articles

Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.

Hu Y, Kaisaki PJ, Argoud K, Wilder SP, Wallace KJ, Woon PY, Blancher C, Tarnow L, Groop PH, Hadjadj S, Marre M, Parving HH, Farrall M, Cox RD, Lathrop M, Vionnet N, Bihoreau MT, Gauguier D.

BMC Med Genomics. 2009 Jul 9;2:41.PMID: 19586551 [PubMed - in process]Related articlesFree article

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

Diabetes Obes Metab. 2009 Oct;11(10):966-77. Epub 2009 Jun 25.PMID: 19558610 [PubMed - in process]Related articles

[Genetics and hypertension]

Ellervik C, Tarnow L, Pedersen EB.

Ugeskr Laeger. 2009 Jun 8;171(24):2012-5. Danish. PMID: 19523364 [PubMed - indexed for MEDLINE]Related articles

Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

Diabetes Care. 2009 Sep;32(9):1684-8. Epub 2009 Jun 5.PMID: 19502542 [PubMed - indexed for MEDLINE]Related articles

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH.

Diabetes. 2009 Jul;58(7):1668-71. Epub 2009 May 1.PMID: 19411615 [PubMed - indexed for MEDLINE]Related articlesFree article

Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.

Lundby Christensen L, Almdal T, Boesgaard T, Breum L, Dunn E, Gade-Rasmussen B, Gluud C, Hedetoft C, Jarloev A, Jensen T, Krarup T, Johansen LB, Lund SS, Madsbad S, Mathiesen E, Moelvig J, Nielsen F, Perrild H, Pedersen O, Roeder M, Sneppen SB, Snorgaard O, Tarnow L, Thorsteinsson B, Vaag A, Vestergaard H, Wetterslev J, Wiinberg N; CIMT Trial Group.

Diabetes Obes Metab. 2009 Apr;11(4):315-22.PMID: 19267709 [PubMed - in process]Related articles

The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.

Möllsten A, Lajer M, Jorsal A, Tarnow L.

Mol Genet Metab. 2009 May;97(1):80-4. Epub 2009 Feb 3.PMID: 19246226 [PubMed - indexed for MEDLINE]Related articles

Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients.

Kjaer A, Kristoffersen US, Tarnow L, Parving HH, Hesse B.

Diabetes Res Clin Pract. 2009 Apr;84(1):34-8. Epub 2009 Feb 23.PMID: 19233497 [PubMed - indexed for MEDLINE]Related articles

[Mannose-binding lectin and mortality in patients with type 2 diabetes mellitus--secondary publication]

Hansen TK, Gall MA, Tarnow L, Thiel S.

Ugeskr Laeger. 2009 Feb 2;171(6):426-9. Danish. PMID: 19213151 [PubMed - indexed for MEDLINE]Related articles

Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.

Bakker SJ, Alkhalaf A, Tarnow L, Navis G.

Diabetes. 2008 Dec;57(12):e16; author reply e17. No abstract available. PMID: 19033401 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. Epub 2008 Oct 9.PMID: 18852875 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.

Hendig D, Tarnow L, Kuhn J, Kleesiek K, Götting C.

Clin Chim Acta. 2008 Dec;398(1-2):90-4. Epub 2008 Aug 28.PMID: 18789912 [PubMed - indexed for MEDLINE]Related articles

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.

Diabetologia. 2008 Nov;51(11):2100-7. Epub 2008 Aug 22.PMID: 18719882 [PubMed - indexed for MEDLINE]Related articles

G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.

Trégouet DA, Groop PH, McGinn S, Forsblom C, Hadjadj S, Marre M, Parving HH, Tarnow L, Telgmann R, Godefroy T, Nicaud V, Rousseau R, Parkkonen M, Hoverfält A, Gut I, Heath S, Matsuda F, Cox R, Kazeem G, Farrall M, Gauguier D, Brand-Herrmann SM, Cambien F, Lathrop M, Vionnet N; EURAGEDIC Consortium.

Diabetes. 2008 Oct;57(10):2843-50. Epub 2008 Jul 15.PMID: 18633107 [PubMed - indexed for MEDLINE]Related articlesFree article

A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes.

Lykke JA, Tarnow L, Parving HH, Hilsted J.

Scand J Clin Lab Invest. 2008 Apr 12:1-6. [Epub ahead of print]PMID: 18609100 [PubMed - as supplied by publisher]Related articles

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.

Leth H, Andersen KK, Frystyk J, Tarnow L, Rossing P, Parving HH, Flyvbjerg A.

J Clin Endocrinol Metab. 2008 Aug;93(8):3186-91. Epub 2008 May 27.PMID: 18505763 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P.

Kidney Int. 2008 Sep;74(5):649-54. Epub 2008 May 21.PMID: 18496510 [PubMed - indexed for MEDLINE]Related articles

The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Lajer M, Ek J, Hansen T, Pedersen O, Parving HH.

Mol Genet Metab. 2008 Jul;94(3):347-51. Epub 2008 May 7.PMID: 18467141 [PubMed - indexed for MEDLINE]Related articles

Urinary proteomics in diabetes and CKD.

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.

J Am Soc Nephrol. 2008 Jul;19(7):1283-90. Epub 2008 Apr 30.PMID: 18448586 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Teerlink T, Gram J, Winther K, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 May;158(5):631-41.PMID: 18426821 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term prevention of diabetic nephropathy: an audit.

Schjoedt KJ, Hansen HP, Tarnow L, Rossing P, Parving HH.

Diabetologia. 2008 Jun;51(6):956-61. Epub 2008 Apr 3.PMID: 18385971 [PubMed - indexed for MEDLINE]Related articles

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.

Persson F, Rossing P, Schjoedt KJ, Juhl T, Tarnow L, Stehouwer CD, Schalkwijk C, Boomsma F, Frandsen E, Parving HH.

Kidney Int. 2008 Jun;73(12):1419-25. Epub 2008 Mar 12.PMID: 18337712 [PubMed - indexed for MEDLINE]Related articles

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of left ventricular function, mass, and volume to NT-proBNP in type 1 diabetic patients.

Astrup AS, Kim WY, Tarnow L, Botnar RM, Simonsen C, Brix L, Pietraszek L, Hansen PR, Manning WJ, Parving HH.

Diabetes Care. 2008 May;31(5):968-70. Epub 2008 Feb 5.PMID: 18252905 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.

Joseph G, Tarnow L, Astrup AS, Hansen TK, Parving HH, Flyvbjerg A, Frystyk J.

J Clin Endocrinol Metab. 2008 Apr;93(4):1470-5. Epub 2008 Jan 22.PMID: 18211979 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes.

Lykke JA, Tarnow L, Parving HH, Hilsted J.

Scand J Clin Lab Invest. 2008;68(7):654-9.PMID: 19378439 [PubMed - indexed for MEDLINE]Related articles

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.

Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2007 Dec;24(12):1381-5. Epub 2007 Oct 29.PMID: 17971180 [PubMed - indexed for MEDLINE]Related articles

European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy.

Tarnow L, Groop PH, Hadjadj S, Kazeem G, Cambien F, Marre M, Forsblom C, Parving HH, Trégouët D, Thévard A, Farrall M, Gut I, Gauguier D, Cox R, Matsuda F, Lathrop M, Vionnet N; EURAGEDIC Consortium.

Nephrol Dial Transplant. 2008 Jan;23(1):161-8. Epub 2007 Aug 17.PMID: 17704113 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.

Spijkerman AM, Gall MA, Tarnow L, Twisk JW, Lauritzen E, Lund-Andersen H, Emeis J, Parving HH, Stehouwer CD.

Diabet Med. 2007 Sep;24(9):969-76. Epub 2007 Jun 25.PMID: 17593241 [PubMed - indexed for MEDLINE]Related articles

Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.

Lajer M, Tarnow L, Jorsal A, Parving HH.

Nephrol Dial Transplant. 2007 Nov;22(11):3235-9. Epub 2007 Jun 13.PMID: 17567649 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag A.

Diabetes Obes Metab. 2007 May;9(3):394-407.PMID: 17391168 [PubMed - indexed for MEDLINE]Related articles

Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations.

Hadjadj S, Tarnow L, Forsblom C, Kazeem G, Marre M, Groop PH, Parving HH, Cambien F, Tregouet DA, Gut IG, Théva A, Gauguier D, Farrall M, Cox R, Matsuda F, Lathrop M, Hager-Vionnet N; EURAGEDIC (European Rational Approach for Genetics of Diabetic Complications) Study Group.

J Am Soc Nephrol. 2007 Apr;18(4):1284-91. Epub 2007 Mar 21.PMID: 17376814 [PubMed - indexed for MEDLINE]Related articlesFree article

CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy.

Lajer M, Tarnow L, Andersen S, Parving HH.

Diabet Med. 2007 Mar;24(3):323-5. No abstract available. PMID: 17305793 [PubMed - indexed for MEDLINE]Related articles

An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes.

Hovind P, Lamberts S, Hop W, Deinum J, Tarnow L, Parving HH, Janssen JA.

Eur J Endocrinol. 2007 Jan;156(1):83-90.PMID: 17218729 [PubMed - indexed for MEDLINE]Related articlesFree article

Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.

Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH.

Circulation. 2007 Jan 16;115(2):228-35. Epub 2006 Dec 26.PMID: 17190865 [PubMed - indexed for MEDLINE]Related articlesFree article

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, Parving HH.

Diabetes. 2006 Dec;55(12):3550-5.PMID: 17130503 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.

Vionnet N, Tregouët D, Kazeem G, Gut I, Groop PH, Tarnow L, Parving HH, Hadjadj S, Forsblom C, Farrall M, Gauguier D, Cox R, Matsuda F, Heath S, Thévard A, Rousseau R, Cambien F, Marre M, Lathrop M.

Diabetes. 2006 Nov;55(11):3166-74.PMID: 17065357 [PubMed - indexed for MEDLINE]Related articlesFree article

Mannose-binding lectin and mortality in type 2 diabetes.

Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A.

Arch Intern Med. 2006 Oct 9;166(18):2007-13.PMID: 17030835 [PubMed - indexed for MEDLINE]Related articlesFree article

The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.

Schön S, Prante C, Bahr C, Tarnow L, Kuhn J, Kleesiek K, Götting C.

Diabetes Care. 2006 Oct;29(10):2295-9.PMID: 17003309 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.

Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.PMID: 16937127 [PubMed - indexed for MEDLINE]Related articles